| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AVTE | Aerovate Therapeutics, Inc. | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Feb 05, 2024 | Option Exercise | $2.02 | 4,600 | 9,284 | 6,209 | Feb 07, 2024, 06:00 PM | |
| AVTE | Aerovate Therapeutics, Inc. | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Feb 05, 2024 | Sale | $17.45 | 4,600 | 80,249 | 1,609 | Feb 07, 2024, 06:00 PM | |
| AVTE | Aerovate Therapeutics, Inc. | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Jan 05, 2024 | Option Exercise | $2.02 | 4,600 | 9,284 | 6,209 | Jan 08, 2024, 06:00 PM | |
| AVTE | Aerovate Therapeutics, Inc. | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Jan 05, 2024 | Sale | $19.16 | 4,600 | 88,116 | 4,083 | Jan 08, 2024, 06:00 PM | |
| AVTE | Aerovate Therapeutics, Inc. | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Dec 05, 2023 | Sale | $16.30 | 4,600 | 74,996 | 1,609 | Dec 07, 2023, 06:00 PM | |
| AVTE | Aerovate Therapeutics, Inc. | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Dec 05, 2023 | Option Exercise | $2.02 | 4,600 | 9,284 | 6,209 | Dec 07, 2023, 06:00 PM | |
| AVTE | Aerovate Therapeutics, Inc. | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Nov 22, 2023 | Option Exercise | $2.02 | 13,800 | 27,852 | 15,409 | Nov 27, 2023, 06:00 PM | |
| AVTE | Aerovate Therapeutics, Inc. | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Nov 22, 2023 | Sale | $15.00 | 13,800 | 207,000 | 1,609 | Nov 27, 2023, 06:00 PM | |
| AVTE | Aerovate Therapeutics, Inc. | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Jul 05, 2023 | Option Exercise | $2.02 | 2,250 | 4,555 | 3,859 | Jul 07, 2023, 06:00 PM | |
| AVTE | Aerovate Therapeutics, Inc. | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Jul 05, 2023 | Sale | $17.30 | 2,250 | 38,915 | 1,828 | Jul 07, 2023, 06:00 PM | |
| AVTE | Aerovate Therapeutics, Inc. | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Jun 05, 2023 | Option Exercise | $2.02 | 2,250 | 4,555 | 3,859 | Jun 07, 2023, 06:00 PM | |
| AVTE | Aerovate Therapeutics, Inc. | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Jun 05, 2023 | Sale | $16.26 | 2,250 | 36,576 | 1,609 | Jun 07, 2023, 06:00 PM | |
| AVTE | Aerovate Therapeutics, Inc. | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | May 05, 2023 | Option Exercise | $2.02 | 2,250 | 4,555 | 3,859 | May 09, 2023, 06:00 PM | |
| AVTE | Aerovate Therapeutics, Inc. | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | May 05, 2023 | Sale | $20.87 | 2,250 | 46,957 | 1,814 | May 09, 2023, 06:00 PM | |
| AVTE | Aerovate Therapeutics, Inc. | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Apr 05, 2023 | Option Exercise | $2.02 | 2,250 | 4,555 | 3,859 | Apr 07, 2023, 06:00 PM | |
| AVTE | Aerovate Therapeutics, Inc. | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Apr 05, 2023 | Sale | $18.20 | 2,250 | 40,942 | 2,144 | Apr 07, 2023, 06:00 PM | |
| AVTE | Aerovate Therapeutics, Inc. | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Mar 06, 2023 | Option Exercise | $2.02 | 2,250 | 4,555 | 3,859 | Mar 08, 2023, 06:00 PM | |
| AVTE | Aerovate Therapeutics, Inc. | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Mar 06, 2023 | Sale | $23.75 | 2,250 | 53,440 | 1,654 | Mar 08, 2023, 06:00 PM | |
| AVTE | Aerovate Therapeutics, Inc. | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Feb 06, 2023 | Option Exercise | $2.02 | 2,250 | 4,555 | 3,859 | Feb 08, 2023, 06:00 PM | |
| AVTE | Aerovate Therapeutics, Inc. | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Feb 06, 2023 | Sale | $24.27 | 2,250 | 54,612 | 1,609 | Feb 08, 2023, 06:00 PM | |
| AVTE | Aerovate Therapeutics, Inc. | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Jan 05, 2023 | Sale | $26.40 | 2,250 | 59,405 | 1,609 | Jan 09, 2023, 06:00 PM | |
| AVTE | Aerovate Therapeutics, Inc. | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Jan 05, 2023 | Option Exercise | $2.02 | 2,250 | 4,555 | 3,859 | Jan 09, 2023, 06:00 PM | |
| AVTE | Aerovate Therapeutics, Inc. | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Dec 05, 2022 | Option Exercise | $2.02 | 2,250 | 4,555 | 3,859 | Dec 07, 2022, 06:00 PM | |
| AVTE | Aerovate Therapeutics, Inc. | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Dec 05, 2022 | Sale | $17.38 | 2,250 | 39,114 | 1,609 | Dec 07, 2022, 06:00 PM | |
| AVTE | Aerovate Therapeutics, Inc. | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Nov 07, 2022 | Option Exercise | $2.02 | 2,250 | 4,555 | 3,859 | Nov 09, 2022, 05:00 PM | |
| AVTE | Aerovate Therapeutics, Inc. | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Nov 07, 2022 | Sale | $19.20 | 2,250 | 43,194 | 3,409 | Nov 09, 2022, 05:00 PM | |
| AVTE | Aerovate Therapeutics, Inc. | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Oct 05, 2022 | Option Exercise | $2.02 | 2,250 | 4,555 | 3,859 | Oct 07, 2022, 05:00 PM | |
| AVTE | Aerovate Therapeutics, Inc. | NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Oct 05, 2022 | Sale | $15.75 | 2,250 | 35,447 | 1,800 | Oct 07, 2022, 05:00 PM | |
| AVTE | Aerovate Therapeutics, Inc. | NIVEN RALPH | Chief Scientific Officer | Sep 06, 2022 | Option Exercise | $2.02 | 2,250 | 4,555 | 3,859 | Sep 07, 2022, 05:30 PM | |
| AVTE | Aerovate Therapeutics, Inc. | NIVEN RALPH | Chief Scientific Officer | Sep 06, 2022 | Sale | $19.00 | 2,250 | 42,750 | 1,609 | Sep 07, 2022, 05:30 PM | |
| AVTE | Aerovate Therapeutics, Inc. | NIVEN RALPH | Chief Scientific Officer | Aug 18, 2022 | Option Exercise | $2.02 | 2,250 | 4,555 | 3,859 | Aug 19, 2022, 05:00 PM | |
| AVTE | Aerovate Therapeutics, Inc. | NIVEN RALPH | Chief Scientific Officer | Aug 18, 2022 | Sale | $21.18 | 2,250 | 47,657 | 1,609 | Aug 19, 2022, 05:00 PM |
Menu